lystn

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
Optimizing Asthma Outcomes: Difficult-to-Treat and Severe Asthma in Primary Care Podcast

Featuring Neil Skolnik, MD as faculty, moderated by Gregg Sherman, MD.

Summary

In this episode, Dr. Skolnick and Dr. Sherman address recent advances in asthma treatment which allow for greater individualization of therapy, particularly for patients with difficult-to-treat and severe asthma.  Available therapies are highly effective for asthma management, yet for a number of reasons,  in practice, asthma is often not optimally controlled.  This podcast will help clinicians recognize how to identify asthma phenotypes to guide therapeutic decision making, incorporate the most recent GINA guidelines into practice, and identify patients with moderate to severe asthma that require more aggressive care, including biologic therapy.

This podcast was recorded and is being used with the permission of the presenters.

Learning Objectives

Upon completion of this activity, learners should be able to:

• Recognize different phenotypes, asthma severity, and modifiable and non-modifiable factors that contribute to poor asthma control in order to make personalized treatment decisions
• Select guideline-directed therapy and patient management strategies, including referral when appropriate, based on individualized characteristics in patients with difficult-to-treat or severe asthma

This activity is accredited for CME/CE credit.
 
 For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
Optimizing Asthma Outcomes: Difficult-to-Treat and Severe Asthma in Primary Care Podcast

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0 hours of pharmacology).

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi Genzyme.